SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR‐T CONSORTIUM. (12th June 2019)

• Record Type: Journal Article
• Authors: Sano, D.; Lekakis, L.; Feng, L.; Nastoupil, L.J.; Jain, M.D.; Spiegel, J.Y.; Dahiya, S.; Lin, Y.; Ghobadi, A.; Lunning, M.; Hill, B.T.; Reagan, P.; Oluwole, O.; McGuirk, J.; Sehgal, A.; Deol, A.; Charalambos, A.; Goy, A.H.; Munoz, J.; Cashen, A.; Bennani, N.N.; Rapoport, A.P.; Vose, J.M.; Miklos, D.B.; Locke, F.L.; Neelapu, S.S.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 304
• Page End: 305
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.113_2630
• Languages: English
• ISSNs: 0278-0232